null

Indusatumab Biosimilar (Anti-GUCY2C) Antibody (HDBS0064)

SKU:
HDBS0064
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Colorectal Cancer
Disease Area:
Gastrointestinal Disorders
Protein:
GUCY2C
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399

Description

system_update_altDatasheet

Indusatumab (Anti-GUCY2C) Biosimilar Antibody (HDBS0064)

The Anti-GUCY2C Indusatu Biosimilar (HDBS0064) is a cutting-edge antibody designed for research involving GUCY2C, a cell surface receptor with implications in cell signaling and gastrointestinal cancer. The biosimilar, developed with advanced technology, shows high specificity and sensitivity in detecting GUCY2C in various cell types, making it a valuable tool for studying molecular pathways and mechanisms related to cancer development and progression.GUCY2C, also known as guanylate cyclase C, plays a vital role in regulating cell growth, differentiation, and survival, making it a promising target for cancer therapy and diagnosis.

By targeting GUCY2C, researchers can explore novel treatment strategies and biomarkers for gastrointestinal cancers, paving the way for personalized medicine approaches in oncology.The Anti-GUCY2C Indusatu Biosimilar (HDBS0064) offers researchers a reliable and efficient means to study the role of GUCY2C in cancer biology and potential therapeutic interventions. With its enhanced performance and specificity, this biosimilar antibody is poised to accelerate discoveries in cancer research and contribute to the development of innovative treatments for patients with gastrointestinal malignancies.